These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9190931)

  • 1. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
    Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
    J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.
    Poindexter NJ; Naziruddin B; McCourt DW; Mohanakumar T
    J Immunol; 1995 Apr; 154(8):3880-7. PubMed ID: 7535816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
    J Immunol; 1996 Jul; 157(2):670-8. PubMed ID: 8752916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes.
    Malarkannan S; Gonzalez F; Nguyen V; Adair G; Shastri N
    J Immunol; 1996 Nov; 157(10):4464-73. PubMed ID: 8906823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
    Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
    Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
    Clayberger C; Parham P; Rothbard J; Ludwig DS; Schoolnik GK; Krensky AM
    Nature; 1987 Dec 24-31; 330(6150):763-5. PubMed ID: 3501071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity.
    Müllbacher A; Hill AB; Blanden RV; Cowden WB; King NJ; Hla RT
    J Immunol; 1991 Sep; 147(6):1765-72. PubMed ID: 1890303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.
    Schendel DJ; Reinhardt C; Nelson PJ; Maget B; Pullen L; Bornkamm GW; Steinle A
    J Immunol; 1992 Oct; 149(7):2406-14. PubMed ID: 1326579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
    Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
    Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as a source of high avidity peptide-specific human CTL.
    Münz C; Obst R; Osen W; Stevanović S; Rammensee HG
    J Immunol; 1999 Jan; 162(1):25-34. PubMed ID: 9886366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.
    Wang RF; Johnston SL; Southwood S; Sette A; Rosenberg SA
    J Immunol; 1998 Jan; 160(2):890-7. PubMed ID: 9551926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
    Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
    Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.